Comprehensive “-omics” interrogation of PDCs derived from one of these models revealed YAP1 as a putative biomarker for treatment response and survival in ~24% of oral squamous cell carcinoma. This evidence concerns the gene YAP1 and oral cavity squamous cell carcinoma.